Revenue

A classic amphibious ATV returns to 'The Price Is Right,' but this isn't just a game show prize. It's a calculated move to power a manufacturing revival.

Robinhood takes an equity stake in Crypto.com's $5B spinoff, OG.com, in a landmark deal to dominate the booming, regulated prediction markets space.

With users and revenue falling, Gamehaus is betting its survival on AI-generated content. Can improved monetization and cost cuts fund this risky transition?

At IFA 2026, display giant BOE unveiled more than new screens; it revealed a sophisticated strategy for European integration. Is this the future of tech globalization?

With 227% H1 revenue growth and a pivotal acquisition, Rapid Nutrition leverages AI and data to pivot from product seller to a vertically integrated platform.

With a new £350M facility, private giant Collinson Group isn't just expanding. It's executing a bold, integrated plan to own the future of travel.

As Crane NXT readies for a key investor conference, its leadership will detail a strategy where trust, traceability, and tech converge to redefine global supply chains.

With sales down and its dividend cut, The Campbell's Company's new leadership faces a critical test at the upcoming Barclays investor conference.

Crescent Electric promotes Kristee Mitchell to Chief Supply Chain Officer, a strategic move to fortify its operations amid industry-wide disruption.

EQT's acquisition of McGill and Partners for $2 billion isn't just another deal. It's a high-stakes validation of a startup that rewrote the rules with tech and trust.

After a sharp stock drop, digital intelligence firm Cellebrite is betting on its advanced AI strategy to win back investors. Can it prove its growth story is real?

Folding bike leader DAHON TECH posts record profits, driven not just by sales, but by a deep strategy of proprietary patents, AI manufacturing, and ecosystem building.

Zscaler posts strong 25% growth, but a projected slowdown and heavy investment reveal a strategic pivot to dominate the security of the coming AI era.

With profits doubling and a massive cash infusion, Mama's Creations is executing a masterclass in growth. But can its operational engine keep pace?

As metal coatings giant AZZ Inc. embarks on a September investor roadshow, we look beyond the stock ticker to see what it reveals about our economy.

HARMAN’s appointment of software veteran Dr. Thomas Irawan signals a strategic shift from vision to execution in the race for the software-defined car.

Cipla and Qilu are teaming up to launch a biosimilar for Keytruda, the world's top cancer drug, signaling a major shift in patient access and market dynamics.

As AI answers replace search, most brand videos are invisible. Videowise's new tech makes authentic user content findable, helping brands build trust and value.

The medtech firm swung from a massive loss to a tiny profit by slashing costs and expanding in the U.S. But is this a sustainable turnaround or a risky gamble?

With a new cancer drug showing promise but cash reserves dwindling, Citius Pharma's CEO faces a critical test: convincing investors the pipeline is worth the risk.